Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 11, 2022

SELL
$38.74 - $62.09 $38,740 - $62,090
-1,000 Closed
0 $0
Q4 2021

Jan 18, 2022

BUY
$35.2 - $53.42 $35,200 - $53,420
1,000 New
1,000 $52,000
Q1 2020

Apr 28, 2020

SELL
$12.31 - $33.12 $43,085 - $115,919
-3,500 Closed
0 $0
Q3 2019

Oct 18, 2019

BUY
$7.47 - $14.03 $26,145 - $49,105
3,500 New
3,500 $2.62 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.87B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Clear Street Markets LLC Portfolio

Follow Clear Street Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Street Markets LLC with notifications on news.